Patient-Oriented Evidence That Matters
Chronic Sinusitis: Saline Irrigation Helps Somewhat; Steroid Does Not Add More Benefit
Am Fam Physician. 2019 Feb 1;99(3):188.
In patients with chronic rhinosinusitis, does the addition of budesonide (Rhinocort) to a saline irrigation solution result in further improvement in symptoms?
This study showed that patients with chronic rhinosinusitis who continue to use a saline nasal wash (NeilMed) will often experience an improvement in symptoms that can be clinically meaningful, but the addition of the corticosteroid budesonide has yet to show an extra benefit. (Level of Evidence = 2b)
These researchers recruited 80 patients with chronic rhinosinusitis (two or more symptoms, including mucopurulent drainage, nasal obstruction, facial pain, and decreased sense of smell for at least 12 weeks) to be randomized, allocation concealment unknown, to receive treatment using a large-volume saline sinus irrigation with placebo or budesonide, 1 mg once daily, for 30 days. The patients, average age 51 years, had a Sino-Nasal Outcome Test score of 44.1 out of a possible 110. A significant number of patients dropped out (23%), leaving 61 to be evaluated. The average decrease in scores was 20.7 points in the treated group and 13.6 points in the control group, which was not statistically significant. More participants in the treated group (79%) received a clinically important benefit of at least a 9-point improvement than in the saline-only group (59%; not statistically different). This small study, with a significant drop-out rate, did not have the power to find a difference if one exists. The authors did not give specific data to judge the degree of benefit beyond a 9-point improvement for the responders.
Study design: Randomized controlled trial (double-blinded)
Funding source: Self-funded or unfunded
Setting: Outpatient (specialty)
Reference: Tait S, Kallogjeri D, Suko J, Kukuljan S, Schneider J, Piccirillo JF. Effect of budesonide added to large-volume, low-pressure saline sinus irrigation for chronic rhinosinusitis: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2018;144(7):605–612.
Editor's Note: Dr. Ebell is Deputy Editor for Evidence-Based Medicine for AFP and cofounder and Editor-in-Chief of Essential Evidence Plus, published by Wiley-Blackwell. Dr. Shaughnessy is an Assistant Medical Editor for AFP.
POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see https://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, Editor-in-Chief.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Mar 1, 2021
Access the latest issue of American Family Physician